SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-010837
Filing Date
2021-08-06
Accepted
2021-08-06 17:01:37
Documents
63
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tgtx-20210630x10q.htm   iXBRL 10-Q 1719264
2 EX-10.1 tgtx-20210630xex10d1.htm EX-10.1 121108
3 EX-31.1 tgtx-20210630xex31d1.htm EX-31.1 13506
4 EX-31.2 tgtx-20210630xex31d2.htm EX-31.2 13484
5 EX-32.1 tgtx-20210630xex32d1.htm EX-32.1 6629
6 EX-32.2 tgtx-20210630xex32d2.htm EX-32.2 6589
  Complete submission text file 0001558370-21-010837.txt   6047472

Data Files

Seq Description Document Type Size
7 EX-101.SCH tgtx-20210630.xsd EX-101.SCH 42218
8 EX-101.CAL tgtx-20210630_cal.xml EX-101.CAL 52716
9 EX-101.DEF tgtx-20210630_def.xml EX-101.DEF 134248
10 EX-101.LAB tgtx-20210630_lab.xml EX-101.LAB 370718
11 EX-101.PRE tgtx-20210630_pre.xml EX-101.PRE 262432
12 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20210630x10q_htm.xml XML 895351
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 211153666
SIC: 2834 Pharmaceutical Preparations